First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
San Diego, CA, and Wayne, PA—Mitchell | Genex, a leading provider of cost containment technology, clinical services, and disabilit
San Diego, CA, and Wayne, PA—Mitchell | Genex, a leading provider of cost containment technology, clinical services, and disabilit
San Diego, CA, and Wayne, PA—Mitchell | Genex, a leading provider of cost containment technology, clinical services, and disabilit
Data analysis by Aarthi Thiruvengadam Over the first few months of the COVID-19 pandemic, the workers’ compensation industry has gone thro
Brand name medications are often scrutinized by the workers’ compensation industry for their high cost.
Part Two: Evaluating In-Network and Out-of-Network Trends In this final post related to our in-network and out-of-network analysis we